Table 2. Summary Table of Findings.
| Quality assessment | No of patients | Effects | Quality | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| No of studies | Design | Risk of bias | Inconsistency | Indirectness | Imprecision | Association | RR | 95% CI | ||
| CKD stage 3 (predicted with: uNGAL) | ||||||||||
| 3 | observational studies | serious | not serious | not serious | not serious | none | 24748 | 1.06 | 0.96~1.18 | VERY LOW |
| CKD stage 3 (predicted with: uKIM-1) | ||||||||||
| 3 | observational studies | serious | not serious | not serious | not serious | weak | 24748 | 1.13 | 1~1.27 | VERY LOW |
| ESRD (predicted with: uNGAL) | ||||||||||
| 4 | observational studies | serious | not serious | not serious | not serious | strong | 19911 | 1.40 | 1.21~1.61 | MEDIUM |
| ESRD (predicted with: uKIM-1) | ||||||||||
| 3 | observational studies | serious | not serious | not serious | not serious | none | 16402 | 1.13 | 0.96~1.33 | VERY LOW |
| ESRD (predicted with: uNAG) | ||||||||||
| 3 | observational studies | serious | not serious | not serious | not serious | none | 16201 | 1.10 | 0.93~1.31 | VERY LOW |
| Mortality (predicted with: uNGAL) | ||||||||||
| 3 | observational studies | serious | serious | not serious | not serious | weak | 4119 | 1.10 | 1.03~1.18 | VERY LOW |
Notes: No, number; RR, relative risk; 95% CI, 95% confidence interval